Study of 99 Million COVID-Vaccinated People Finds Links to Brain, Heart Problems; Suffering from Heart, Brain Disorders? Global Study Links COVID-19 Vaccines with 13 Medical Conditions, and other C-Virus related stories

Study of 99 million COVID-vaccinated people finds links to brain, heart problems:

In what stands as one of the most comprehensive vaccine safety studies across the globe, scientists have singled out unusual conditions that have surfaced after receiving COVID-19 vaccinations.

The study of 99 million vaccinated people in eight countries found a slight increase in heart inflammation cases following shots from Pfizer and Moderna, both mRNA vaccines.

Simultaneously, the AstraZeneca vaccine, which uses a different technology known as a viral vector, has been associated with a rare brain blood clot disorder.

The AstraZeneca vaccine has also been linked to a higher risk of Guillain-Barre syndrome, a neurological disorder that can sometimes lead to muscle weakness and, in rare instances, paralysis.

These findings are particularly significant against the backdrop of the 13.5 billion doses of COVID-19 vaccines administered globally to date — an undertaking that has played a critical role in preserving lives during the pandemic.

The Global Vaccine Data Network’s exhaustive research, detailed in the scholarly journal Vaccine, provides expansive insight into the matter. The network’s publication, equipped with easy-to-navigate dashboards, transparently presents both its research methodology and the conclusions drawn for public examination.

The analysts involved in this study examined health data of 99 million individuals, primarily focused on 13 specific conditions considered to be of special interest for vaccine safety. —>READ MORE HERE

Suffering from heart, brain disorders? Global study links COVID-19 vaccines with 13 medical conditions:

The COVID-19 vaccines that emerged as a beacon of hope in the fight against the deadly virus during the pandemic are back in the news again following a new study that has linked the shots to rare brain, heart and blood disorders, Vaccine, a science journal, reported last week.

The journal reported that researchers from the Global Vaccine Data Network—a research arm of the World Health Organization—found that the COVID-19 vaccines aggravated 13 medical conditions that were considered “adverse events of special interest.”

The study conducted on 99 million vaccinated people from eight countries: Argentina, Australia, Canada, Denmark, Finland, France, New Zealand and Scotland, reported that people who received certain types of mRNA vaccines were found to have a higher risk of myocarditis, which is inflammation of the heart muscle.

The Key Findings

Rare cases of myocarditis—inflammation of the heart—identified in the first, second and third doses of Pfizer-BioNTech’s and Moderna’s mRNA vaccines: The highest rate was observed after the second dose of Moderna vaccine (with 6.1 times compared to the expected rates), Forbes reported, citing the study.

Pericarditis (another heart condition): Up to 6.9 times increased risk of Pericarditis in individuals who received the third dose of AstraZeneca’s vaccine. The study reported 1.7 times and 2.6 times increased risks in recipients of Moderna’s first and fourth doses, respectively.

The study also reported a greater risk of developing a rare autoimmune disorder — Guillain-Barre syndrome – among those who took the AstraZeneca shots, and had 3.2 times the risk of getting blood clots.

Disseminated encephalomyelitis: The study also reported a 3.8 times greater risk of developing the neurological disorder acute disseminated encephalomyelitis after taking the Moderna vaccine, and a 2.2-fold increased risk after AstraZeneca’s vaccine.

However, the experts stressed that the benefits of the COVID-19 vaccination far outweigh the risks. They said the likelihood of neurological events or heart inflammation is significantly higher after COVID-19 infection rather than after receiving a COVID-19 shot.

“The odds of all of these adverse events is still much, much higher when infected with SARS-CoV-2 (COVID-19), so getting vaccinated is still by far the safer choice,” CEO of biotechnology company Centivax Jacob Glanville, who is not involved in the study, told Forbes. —>READ MORE HERE

Follow links below to relevant/related stories and resources:

Scientists Discover New Class of Antivirals That Work Against COVID



Federal court dismisses case against Iowa governor’s ban on school mask mandates



USA TODAY: Coronavirus Updates

WSJ: Coronavirus Live Updates

YAHOO NEWS: Coronavirus Live Updates

NEW YORK POST: Coronavirus The Latest

Source

Jesus Christ is King